{
    "nctId": "NCT06604247",
    "briefTitle": "The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients",
    "officialTitle": "The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Prostate Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 18,
    "primaryOutcomeMeasure": "Fatigue",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of organ-confined breast cancer or prostate cancer\n* Received radiation treatment\n* Willing and able to provide informed consent\n* Endorse problem with both insomnia and cancer-related fatigue, as measured by the insomnia severity index, Multidimensional Fatigue Symptom Inventory (short form) and the Brief Fatigue Inventory\n\nExclusion Criteria:\n\n* History of obstructive Sleep Apnea\n* History of narcolepsy\n* Night shift work\n* Distant metastatic disease at presentation\n* Active drug/alcohol dependence",
    "sex": "ALL",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}